Skip to main content
KARBF logo

Karo Pharma AB (publ) (KARBF) Stock Analysis

DELISTED

What happened to Karo Pharma AB (publ) (KARBF) stock?

Karo Pharma AB (publ) (KARBF) no longer trades on public markets. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
MCap: $1.52B| Vol: 1.0K| 52-wk range: $5.25 – $5.71

Market cap $1.52B is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Karo Pharma AB (publ) (KARBF). Karo Pharma AB (publ) develops and markets prescription drugs and over-the-counter products. The company focuses on the Nordic region and Europe, with sales in approximately 90 countries.

Last analyzed: Mar 17, 2026
Karo Pharma AB (publ) develops and markets prescription drugs and over-the-counter products. The company focuses on the Nordic region and Europe, with sales in approximately 90 countries.

Karo Pharma AB (publ) (KARBF) Healthcare & Pipeline Overview

Model self-rating on this text: 81% (not a measure of the evidence) Updated: Mar 17, 2026

KARBF OTC Market Information

KARBF trades on the OTC Other market tier of OTC Markets.

  • OTC Tier: OTC Other

More about this archive record

Can I still buy KARBF shares?

No. KARBF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for KARBF elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before KARBF stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Karo Pharma AB (publ). An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.